What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence-Reference-Cited by-同舟云学术

What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence

Published:2006-07 Issue:1 Volume:102 Page:103-110
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Foulmann Katy,Guastalla Jean-Paul,Caminet Nadège,Trillet-Lenoir Véronique,Raudrant Daniel,Golfier François,Schott Anne-Marie

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference33 articles.

1. Epidemiology and aetiology of gestational trophoblastic diseases;Altieri;Lancet Oncol.,2003

2. Effects of methotrexate therapy upon choriocarcinomas and chorioadenomas;Li;Proc. Soc. Exp. Biol. Med.,1956

3. Five years experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women;Hertz;Am. J. Obstet. Gynecol.,1961

4. Risk and prognostic factors in trophoblastic neoplasia;Bagshawe;Cancer,1976

5. Infusion therapy for pelvic trophoblastic tumors;Bagshawe;J. Obstet. Gynaecol. Br. Commonw.,1964

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vivo Quantitative Assessment of Gestational Choriocarcinoma Development and Progression Using Luminescent Trophoblast Cells;Methods in Molecular Biology;2023-11-30

2. Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8‐day regimen for treatment of low‐risk gestational trophoblastic neoplasia;Asia-Pacific Journal of Clinical Oncology;2021-06-29

Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy

;Cancer Management and Research;2020-06

4. Dose Issues in Cancer Chemotherapy;Oncology;2020

5. Eight days versus weekly intramuscular methotrexate for the treatment of low-risk gestational trophoblastic neoplasia;European Journal of Gynaecological Oncology;2020